Wednesday, January 14, 2009

According to Jon Najarian's Tuesday Stock Blog, which biotech saw options trading spike on Eli Lilly deal rumors?

Squawk on the Street

Question: According to Jon Najarian's Tuesday Stock Blog, which biotech saw options trading spike on Eli Lilly deal rumors?

Answer: DNDN

Get the Answer: According to Jon Najarian's Tuesday Stock Blog, which biotech saw options trading spike on Eli Lilly deal rumors?

Posted by Alzheimer's Reading Room at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)